Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pieter Annaert

Showing results (11-20 of 221) with videos related to

Pageof 23
Sort By:
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|February 12, 2013
Site dependent intestinal absorption of darunavir and its interaction with ketoconazoleJef Stappaerts, Pieter Annaert, Patrick Augustijns
International Journal of Pharmaceutics|April 17, 2012
Drug disposition and clinical practice in neonates: cross talk between developmental physiology and pharmacologyAnne Smits, Pieter Annaert, Karel Allegaert
Pharmaceutics|January 26, 2024
Interdisciplinary Collaboration on Real World Data to Close the Knowledge Gap: A Reflection on "De Sutter et al. Predicting Volume of Distribution in Neonates: Performance of Physiologically Based Pharmacokinetic Modelling"Karel Allegaert, Anne Smits, Pieter Annaert
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 19, 2008
Cellular accumulation of cholyl-glycylamido-fluorescein in sandwich-cultured rat hepatocytes: kinetic characterization, transport mechanisms, and effect of human immunodeficiency virus protease inhibitorsZhi-Wei Ye, Patrick Augustijns, Pieter Annaert
Journal of Pharmaceutical Sciences|June 24, 2011
Influence of drug transport proteins on the pharmacokinetics and drug interactions of HIV protease inhibitorsLatoya Griffin, Pieter Annaert, Kim L R Brouwer
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 17, 2010
In situ intestinal perfusion in knockout mice demonstrates inhibition of intestinal p-glycoprotein by ritonavir causing increased darunavir absorptionNico Holmstock, Raf Mols, Pieter Annaert, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|July 31, 2012
Drug precipitation-permeation interplay: supersaturation in an absorptive environmentJan Bevernage, Joachim Brouwers, Pieter Annaert, et al.
Biopharmaceutics & Drug Disposition|June 26, 2010
Validation of a differential in situ perfusion method with mesenteric blood sampling in rats for intestinal drug interaction profilingJoachim Brouwers, Raf Mols, Pieter Annaert, et al.
British Journal of Clinical Pharmacology|February 8, 2017
Response to: 'Bodyweight-adjustments introduce significant correlations between CYP3A metrics and tacrolimus clearance'Thomas Vanhove, Pieter Annaert, Dirk R J Kuypers
Toxicology and Applied Pharmacology|November 12, 2013
Hepatocyte-based in vitro model for assessment of drug-induced cholestasisSagnik Chatterjee, Lysiane Richert, Patrick Augustijns, et al.
Pageof 23

Showing results (11-20 of 221) with videos related to

Sort By:
Pageof 23
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|February 12, 2013
Site dependent intestinal absorption of darunavir and its interaction with ketoconazoleJef Stappaerts, Pieter Annaert, Patrick Augustijns
International Journal of Pharmaceutics|April 17, 2012
Drug disposition and clinical practice in neonates: cross talk between developmental physiology and pharmacologyAnne Smits, Pieter Annaert, Karel Allegaert
Pharmaceutics|January 26, 2024
Interdisciplinary Collaboration on Real World Data to Close the Knowledge Gap: A Reflection on "De Sutter et al. Predicting Volume of Distribution in Neonates: Performance of Physiologically Based Pharmacokinetic Modelling"Karel Allegaert, Anne Smits, Pieter Annaert
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 19, 2008
Cellular accumulation of cholyl-glycylamido-fluorescein in sandwich-cultured rat hepatocytes: kinetic characterization, transport mechanisms, and effect of human immunodeficiency virus protease inhibitorsZhi-Wei Ye, Patrick Augustijns, Pieter Annaert
Journal of Pharmaceutical Sciences|June 24, 2011
Influence of drug transport proteins on the pharmacokinetics and drug interactions of HIV protease inhibitorsLatoya Griffin, Pieter Annaert, Kim L R Brouwer
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 17, 2010
In situ intestinal perfusion in knockout mice demonstrates inhibition of intestinal p-glycoprotein by ritonavir causing increased darunavir absorptionNico Holmstock, Raf Mols, Pieter Annaert, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|July 31, 2012
Drug precipitation-permeation interplay: supersaturation in an absorptive environmentJan Bevernage, Joachim Brouwers, Pieter Annaert, et al.
Biopharmaceutics & Drug Disposition|June 26, 2010
Validation of a differential in situ perfusion method with mesenteric blood sampling in rats for intestinal drug interaction profilingJoachim Brouwers, Raf Mols, Pieter Annaert, et al.
British Journal of Clinical Pharmacology|February 8, 2017
Response to: 'Bodyweight-adjustments introduce significant correlations between CYP3A metrics and tacrolimus clearance'Thomas Vanhove, Pieter Annaert, Dirk R J Kuypers
Toxicology and Applied Pharmacology|November 12, 2013
Hepatocyte-based in vitro model for assessment of drug-induced cholestasisSagnik Chatterjee, Lysiane Richert, Patrick Augustijns, et al.
Pageof 23